FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, particularly to a novel pyrazolopyridine derivative of formula 
(I), as well as to a tautomer, geometric isomer and optically active forms thereof, such as enantiomers, diastereomers and racemates, and to pharmaceutically acceptable salts thereof, where G1 is selected from -C(O)-R1; R1 is selected from C1-C6-alkoxy-C1-C6-alkyl; C1-C6-alkyl; substituted C6-aryl-C1-C6-alkyl; substituted piperidine; G2 is selected from optionally substituted C6-aryl; G3 is selected from C1-C6-alkyl; G4 is selected from pyridine-C1-C6-alkyl; G5 is selected from H; where the term "substituted" denotes groups substituted with one substitute selected from a group which includes "C1-C6-alkyl", "C1-C6-alkoxy", "C1-C6-alkoxycarbonyl" and "halogen". The invention also relates to a specific compound and a pharmaceutical composition based on a pyrazolopyridine derivative.
EFFECT: obtaining novel pyrazolopyridine derivative having the capacity to inhibit NADPH oxidase.
10 cl, 2 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
| PYRAZOLE PYRIDINE DERIVATIVES AS NADPH-OXIDASE | 2009 |
|
RU2548022C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS | 2009 |
|
RU2532161C2 |
| 2,3-SUBSTITUTED PYRAZINE SULPHONAMIDES AS CRTH2 INHIBITORS | 2006 |
|
RU2453540C2 |
| PURINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684644C1 |
| 1,3-DIARYL-SUBSTITUTED UREAS AS KINASE ACTIVITY MODULATORS | 2006 |
|
RU2402544C2 |
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
| IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677699C1 |
| 8-CARBAMOYL-2-(2,3-DI-SUBSTITUTED PYRID-6-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AS APOPTOSIS-INDUCING AGENTS FOR CANCER TREATMENT | 2012 |
|
RU2625315C2 |
| CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
